We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$2.05B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+14.8%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.85B
AUM Growth
+$181M
(+11%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WEX
WEX
|
+$25M |
| 2 |
Amdocs
DOX
|
+$10.9M |
| 3 |
Etsy
ETSY
|
+$9.39M |
| 4 |
Gentex
GNTX
|
+$8.86M |
| 5 |
MGP Ingredients
MGPI
|
+$6.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$16.8M |
| 2 |
Pacira BioSciences
PCRX
|
+$12.5M |
| 3 |
ADMA Biologics
ADMA
|
+$11.5M |
| 4 |
ACI Worldwide
ACIW
|
+$9.89M |
| 5 |
RXO
RXO
|
+$8.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.6% |
| 2 | Technology | 28.67% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Staples | 6.67% |
| 5 | Communication Services | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Accuray
ARAY
$34.9M
| – | – |
-310,252
| Closed | -$565K |
|
252
American Vanguard Corp
AVD
$65.5M
| – | – |
-165,169
| Closed | -$1.42M |
|
253
Five Below
FIVE
$13B
| – | – |
-19,481
| Closed | -$2.12M |
|
|
HI
254
DELISTED
Hillenbrand
HI
| – | – |
-38,998
| Closed | -$1.56M |
|
255
HUB Group
HUBG
$2.9B
| – | – |
-36,892
| Closed | -$1.59M |
|
256
Karat Packaging
KRT
$960M
| – | – |
-80,351
| Closed | -$2.38M |
|
257
Merck
MRK
$323B
| – | – |
-1,769
| Closed | -$219K |
|
258
Navitas Semiconductor
NVTS
$3.44B
| – | – |
-547,247
| Closed | -$2.15M |
|
259
Puma Biotechnology
PBYI
$442M
| – | – |
-144,792
| Closed | -$472K |
|
|
PINC
260
DELISTED
Premier
PINC
| – | – |
-204,835
| Closed | -$3.82M |
|
261
Qualys
QLYS
$6.43B
| – | – |
-29,967
| Closed | -$4.27M |
|
|
262
RXO
RXO
$3.52B
| – | – |
-320,015
| Closed | -$8.37M |
|
263
Rhythm Pharmaceuticals
RYTM
$7.95B
| – | – |
-93,081
| Closed | -$3.82M |
|
|
SRDX
264
DELISTED
Surmodics
SRDX
| – | – |
-65,255
| Closed | -$2.74M |
|
265
TriCo Bancshares
TCBK
$1.82B
| – | – |
-50,136
| Closed | -$1.98M |
|
|
THS
266
DELISTED
Treehouse Foods
THS
| – | – |
-10,136
| Closed | -$371K |
|
267
Upwork
UPWK
$1.21B
| – | – |
-137,781
| Closed | -$1.48M |
|
268
XPEL
XPEL
$1.31B
| – | – |
-42,423
| Closed | -$1.51M |
|
|
IRD
269
Opus Genetics
IRD
$302M
| – | – |
-223,589
| Closed | -$342K |
|
|
LUCK
270
Lucky Strike Entertainment
LUCK
$893M
| – | – |
-225,655
| Closed | -$3.27M |
|
|
PWSC
271
DELISTED
PowerSchool Holdings, Inc.
PWSC
| – | – |
-178,585
| Closed | -$4M |
|
|
WKME
272
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| – | – |
-338,422
| Closed | -$4.73M |
|
Similar funds
RC
GIM
IL
BC
SAM
AG
TA
ACP
Rice Hall James & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Rice Hall James & Associates held 272 positions worth $1.85B, up 11% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Rice Hall James & Associates's Q3 2024 filing shows 16 new, 74 increased, 154 reduced and 22 closed positions. Its largest new stake was Gentex: 285,297 shares worth $8.47M. The largest sale was Axos Financial, an estimated $16.8M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
- Rice Hall James & Associates's largest Q3 2024 buy was Gentex: 285,297 shares worth $8.47M.
- Rice Hall James & Associates added most to WEX in Q3 2024, an estimated $25M increase.
- Rice Hall James & Associates's biggest Q3 2024 reduction was Axos Financial, cutting an estimated $16.8M.
- Rice Hall James & Associates fully exited RXO in Q3 2024, selling an estimated $8.37M.
- Rice Hall James & Associates's ten largest holdings make up 26% of its $1.85B portfolio in Q3 2024.
- Rice Hall James & Associates opened 16 new positions and closed 22 in Q3 2024.
- Rice Hall James & Associates's portfolio value rose 11% quarter-over-quarter to $1.85B.
Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.